Answer – Problems with the regulatory criteria for endocrine disruptors – E-006622/2016

The draft acts put forward on 15 June 2016 by the Commission(1) set criteria to identify endocrine disruptors based on the widely agreed definition of an endocrine disruptor issued in 2012 by the World Health Organisation and the International Programme for Chemical Safety.

The draft acts give clear, specific and attainable criteria for identifying endocrine disruptors making use of all relevant scientific evidence, using a weight of evidence approach, and applying a robust systematic review.

During the summer of 2016, the two draft legal acts were subject to the feedback mechanism and were notified to the World Trade Organisation to allow third parties to comment. They are now in consultation with experts of Member States before finally being adopted according to the foreseen procedures, i.e. a delegated act under the Biocidal Products Regulation(2) and the so-called PRAC procedure (Procédure de Réglementation avec Contrôle) under the Plant Protection Products Regulation(3).

The consultation on the delegated act also involves experts from the European Parliament, who attend the relevant expert meetings. These procedures ensure that the drafts are scrutinised not only by the Member States, but also by the European Parliament and the Council.

(1) http://ec.europa.eu/health/endocrine_disruptors/policy/index_en.html
(2) OJ L 167, 27.6.2012, p. 1
(3) OJ L 309, 24.11.2009, p. 1

Leave a Reply